Relmada Therapeutics (RLMD) Prepaid Assets (2012 - 2026)
Relmada Therapeutics' (RLMD) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, up 918.56% year-on-year from $135500.0 in Q1 2025, and up 41.16% on a QoQ basis from $977721.0 in Q4 2025.
Relmada Therapeutics (RLMD) Prepaid Assets (2012 - 2026) Analysis & Trends
Relmada Therapeutics (RLMD) has 14 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 918.56% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 918.56% increase from a year earlier, with the FY2025 full-year figure at $977721.0, up 10.29% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.4 million, up from $977721.0 in the prior quarter.
- Over the last five years, Prepaid Assets for RLMD reached as high as $4.0 million in Q4 2022 and fell as low as $99500.0 in Q2 2025.
- Historically, Prepaid Assets has averaged $1.6 million across 5 years, with a median of $967700.0 in 2025.
- Across the five-year window, Prepaid Assets surged 4430.17% in 2022 and slumped 91.42% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $4.0 million in 2022, then tumbled by 82.78% to $695000.0 in 2023, then advanced by 27.55% to $886461.0 in 2024, then grew by 10.29% to $977721.0 in 2025, then jumped by 41.16% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.4 million in Q1 2026, $977721.0 in Q4 2025, and $967700.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 977,721.00 |
| Sep 30, 2025 | 967,700.00 |
| Jun 30, 2025 | 99,500.00 |
| Mar 31, 2025 | 135,500.00 |
| Dec 31, 2024 | 886,461.00 |
| Sep 30, 2024 | 243,300.00 |
| Jun 30, 2024 | 537,522.00 |
| Mar 31, 2024 | 752,334.00 |
| Dec 31, 2023 | 695,000.00 |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 4.04 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 144,700.00 |
| Dec 31, 2021 | 11.30 Mn |
| Sep 30, 2021 | 136,900.00 |
| Jun 30, 2021 | 76,900.00 |